
<HTML>
<HEAD>
<TITLE>8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">







<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, DC 20549</B>
</DIV>


<P align="center" style="font-size: 10pt"><HR size="1" noshade width="25%" align="center">


<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 10pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 OR 15(d) of the<BR>
Securities Exchange Act of 1934</B>



<P align="left" style="font-size: 10pt">Date of Report (Date of earliest event reported) <B>December&nbsp;23, 2004</B>


<P align="center" style="font-size: 24pt"><B>DATATRAK International, Inc.</B>

<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="100%" align="LEFT">
(Exact Name of Registrant as Specified in Charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Ohio</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-20699</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>34-1685364</B></TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left"><HR size="1" noshade width="100%" align="LEFT"></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction<BR>
of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission<BR>
File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>6150 Parkland Boulevard, Mayfield Hts., Ohio</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>44124</B></TD>
</TR>
<TR valign="bottom">

<TD colspan="3" valign="top" align="left"><HR size="1" noshade width="100%" align="LEFT"></TR><TR>
<TD align="center" valign="top">(Address of Principal Executive Offices)</TD>
<TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>

</TR>

<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt">Registrant&#146;s telephone number, including area code <B>440-443-0082</B>



<P align="center" style="font-size: 10pt">N/A

<HR size="1" noshade width="100%" align="LEFT">
<div align="center" style="font-size: 10pt">(Former Name or Former Address, if Changed Since Last Report.)</DIV>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


<P>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">








<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link2 "Item&nbsp;1.01 Entry into a Material Definitive Agreement. " -->

<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;23, 2003, DATATRAK International, Inc. (the &#147;Company&#148;) agreed to the terms of a
private placement with a group of institutional investors who agreed to invest in the Company
an aggregate principal amount of approximately $4.6&nbsp;million. On
December 28, 2004, the private placement closed and the Company sold
and issued 486,313 shares of common stock, no par value (the &#147;Common Shares&#148;) at a price of $9.50 per share
and the Company received net proceeds from the offering of
approximately $4.4&nbsp;million.
The Company also issued warrants to purchase a total of up to 72,948 Common Shares to the
investors at an exercise price of $14.40 with an expiration date of December&nbsp;23, 2007. The Company
issued warrants, on the same terms, to purchase an
additional 21,316 Common Shares to
a placement agent who assisted the Company in the private placement, as partial compensation for
the placement agent&#146;s services, The Company also granted
registration rights for the purchased Common
Shares and the Common Shares issuable upon exercise of the warrants.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Copies of the documents governing these transactions are filed as exhibits to this report and
are incorporated in this report by reference. The above description of the transactions is
qualified in its entirety by the attached documents.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;24, 2004, the Company issued a press release, announcing the signing of
documentation regarding the private placement, which is attached to
this report as Exhibit&nbsp;99.1. On December 28, 2004, the Company
issued a press release, announcing the closing of the private
placement, which is attached to this report as Exhibit 99.2.

<!-- link2 "Item&nbsp;3.02 Unregistered Sales of Equity Securities." -->

<P align="left" style="font-size: 10pt"><B>Item&nbsp;3.02 Unregistered Sales of Equity Securities.</B>
<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
December 28, 2004, the Company issued 486,313 Common Shares to a
group of institutional investors and warrants to purchase a total of
up to 94,264 Common Shares at $14.40 per share to the investors and a
placement agent.
<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Common Shares were issued pursuant to an exemption or exemptions
from  registration under Section 4(2) of the Securities Act of 1933,
as amended (&#147;Securities Act&#148;) and/or Regulation D
promulgated under the Securities Act.

<!-- link2 "Item&nbsp;9.01 Financial Statements and Exhibits." -->

<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(c)&nbsp;Exhibits.</B>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="9%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Share Purchase Agreement among DATATRAK International, Inc. and the Purchasers named therein, dated December&nbsp;23, 2004, including Form of Warrant for Common Shares.</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="9%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">99.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Press release issued by DATATRAK International, Inc. on December&nbsp;24, 2004.</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="9%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">99.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Press release issued by DATATRAK International, Inc. on
December&nbsp;28, 2004.</TD>
</TR>

</TABLE>

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain statements made in this Form 8-K, other SEC filings or written materials or orally
made by the Company or its representatives may constitute forward-looking statements that are based
on management&#146;s current beliefs, estimates and assumptions concerning the operations, future
results and prospects of the Company and the clinical pharmaceutical research industry in general.
All statements that address operating performance, events or developments that management
anticipates will occur in the future, including statements related to future revenue, profits,
expenses, income and earnings per share or statements expressing general optimism about future
results, are forward-looking statements within the meaning of Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended (&#147;Exchange Act&#148;). In addition, words such as &#147;expects,&#148;
&#147;anticipates,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; variations of such words, and similar
expressions are intended to identify forward-looking statements. Forward-looking statements are
subject to the safe harbors created in the Exchange Act. Factors that may cause actual results to
differ materially from those in the forward-looking statements include the ability of the Company


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">to absorb corporate overhead and other fixed costs in order to successfully market the
DATATRAK EDC&#153; software; the development of and fluctuations in the market for electronic data
capture technology; the degree of the Company&#146;s success in obtaining new contracts; the timing of
payments from customers and the timing of clinical trial sponsor decisions to conduct new clinical
trials or cancel or delay ongoing trials; governmental regulation; the early stage of the Company&#146;s
ASP operations; and general economic conditions such as the rate of employment, inflation, interest
rates and the condition of capital markets. This list of factors is not all inclusive. In addition,
the Company&#146;s success depends on the outcome of various strategic initiatives it has undertaken,
all of which are based on assumptions made by the Company concerning trends in the clinical
research market and the health care industry. Any forward-looking statement speaks only as of the
date on which such statement is made and the Company does not undertake any obligation to update
any statements whether as a result of new information, future events or otherwise.


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "SIGNATURES" -->

<P align="left" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DATATRAK INTERNATIONAL, INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Date December&nbsp;28, 2004
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By&nbsp;&nbsp;&nbsp;/s/ Terry C. Black<BR></TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" width="45%" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Terry C. Black<br>
Vice President of Finance, Chief<br>
Financial Officer, Treasurer and<br>
Assistant Secretary</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="15%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Description</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Share Purchase Agreement among DATATRAK International, Inc. and the Purchasers named therein, dated December&nbsp;23, 2004, including form of Warrant for Common Shares.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release issued by DATATRAK International, Inc. on December&nbsp;24, 2004.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release issued by DATATRAK
International, Inc. on December&nbsp;28, 2004.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">5
</DIV>
</BODY>
</HTML>

